Hyperhidrosis Clinical Trial
Official title:
How Far Should The Needle Be Withdrawn for Stellate Ganglion Block: Determination of Longus Colli Muscle Thickness by Ultrasonography
NCT number | NCT05108103 |
Other study ID # | 2021/182 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2021 |
Est. completion date | June 1, 2022 |
Verified date | September 2022 |
Source | Istanbul University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to assess the longus colli muscle thickness by ultrasonography in order to guide stellate ganglion blocks
Status | Completed |
Enrollment | 200 |
Est. completion date | June 1, 2022 |
Est. primary completion date | March 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age between 18 - 65 years, - Giving informed consent for examination, ultrasonographic evaluation and study participation Exclusion Criteria: - Having a chronic neck pain for more than 6 months, - Having any neurological or musculoskeletal conditions that may affect the anatomy of cervical region (cervical disc herniation, torticollis, severe scoliosis, vertebral malformation, spinal stenosis, myopathies, etc.) - Having a history of surgery or radiation therapy in the cervical region |
Country | Name | City | State |
---|---|---|---|
Turkey | Halil Çetingök | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Istanbul University |
Turkey,
Ates Y, Asik I, Ozgencil E, Açar HI, Yagmurlu B, Tekdemir I. Evaluation of the longus colli muscle in relation to stellate ganglion block. Reg Anesth Pain Med. 2009 May-Jun;34(3):219-23. doi: 10.1097/AAP.0b013e3181a32a02. — View Citation
Narouze S. Ultrasound-guided stellate ganglion block: safety and efficacy. Curr Pain Headache Rep. 2014 Jun;18(6):424. doi: 10.1007/s11916-014-0424-5. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Distance between corpus and longus colli muscle's anterior border on C6 level (millimeters) | Distance between corpus and longus colli muscle's anterior border on C6 level will be evaluated with ultrasonography. | 0 minutes | |
Secondary | Distance between corpus and longus colli muscle's anterior border on C7 level (millimeters) | Distance between corpus and longus colli muscle's anterior border on C7 level will be evaluated with ultrasonography. | 0 minutes | |
Secondary | Maximum anteroposterior width of longus colli muscle on C6 level (millimeters) | Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography. | 0 minutes | |
Secondary | Maximum anteroposterior width of longus colli muscle on C7 level (millimeters) | Maximum anteroposterior width of longus colli muscle on C6 level will be evaluated with ultrasonography. | 0 minutes | |
Secondary | Distance between esophagus and estimated needle plane (millimeters) | Distance between esophagus and estimated needle plane will be evaluated with ultrasonography. | 0 minutes | |
Secondary | Neck circumference (centimeters) | Neck circumference | 0 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04924036 -
Qbrexza Cloths for Hyperhidrosis of Amputation Sites
|
Phase 2 | |
Recruiting |
NCT04178161 -
Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis
|
N/A | |
Completed |
NCT02552199 -
A Non-Interventional Study To Assess Sweating
|
||
Completed |
NCT02565732 -
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
|
Phase 2 | |
Recruiting |
NCT01930604 -
Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis
|
Phase 2 | |
Completed |
NCT01811004 -
Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis
|
N/A | |
Completed |
NCT01671800 -
Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating
|
Phase 1 | |
Completed |
NCT01956591 -
Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis
|
N/A | |
Completed |
NCT01934153 -
Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects
|
Phase 1 | |
Completed |
NCT06113978 -
Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18
|
N/A | |
Not yet recruiting |
NCT05102396 -
Topical Oxybutynin for Treatment of Hyperidrosis: a Local or a Systemic Effect?
|
Phase 2 | |
Completed |
NCT04906655 -
An Open Label Study for Palmar Hyperhydrosis
|
Phase 2 | |
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Completed |
NCT02563899 -
Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis
|
Phase 2 | |
Withdrawn |
NCT05546710 -
miraDry Post Market Tumescent Anesthesia Study
|
N/A | |
Completed |
NCT02016885 -
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
|
Phase 2 | |
Completed |
NCT00168480 -
A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
|
Phase 4 | |
Completed |
NCT03416348 -
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
|
Phase 1 | |
Completed |
NCT02973659 -
The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.
|
N/A | |
Not yet recruiting |
NCT05805696 -
Treatment and Mapping of Impostor Phenomenon
|
N/A |